• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度:囊性纤维化新生儿筛查的最后也是最佳前沿阵地及特殊挑战透视

India: The Last and Best Frontier for Cystic Fibrosis Newborn Screening with Perspectives on Special Challenges.

作者信息

Farrell Philip M, Paul Grace R, Varkki Sneha D

机构信息

Departments of Pediatrics and Population Health Sciences, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison, WI 53792, USA.

Division of Pulmonary and Sleep Medicine, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43025, USA.

出版信息

Int J Neonatal Screen. 2025 Apr 17;11(2):27. doi: 10.3390/ijns11020027.

DOI:10.3390/ijns11020027
PMID:40265448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12015907/
Abstract

Because a delayed diagnosis of cystic fibrosis (CF) is detrimental and may be fatal, screening at birth has become routine in the Western world and has proven beneficial for many reasons, in addition to enabling prompt specialized care. Newborn screening (NBS) programs have elucidated the true incidence of CF in a variety of populations and enabled rapid genotype identification through the analysis of the cystic fibrosis transmembrane regulator () gene. NBS studies also have revealed regional and population differences in variants and refuted the dogma that CF is a "white person's disease". But some regions have not yet implemented CF NBS, particularly in Asia where the disease prevalence has been uncertain. While the needs of a few low-and-middle-income countries are being addressed sequentially, one of the regions of greatest current interest is the Indian subcontinent because of recent data suggesting a higher incidence than that previously assumed, and clinical observations indicating tragic outcomes due to delayed diagnoses or failure to diagnose the disorder in young children. Thus, we conclude that the opportunities for research combined with service in the Indian subcontinent are urgent and potentially very impactful. Consequently, India is the for CF NBS, as we argue herein.

摘要

由于囊性纤维化(CF)的延迟诊断有害且可能致命,在西方世界,出生时进行筛查已成为常规做法,并且除了能够提供及时的专科护理外,还因多种原因被证明是有益的。新生儿筛查(NBS)项目已经阐明了CF在各种人群中的真实发病率,并通过分析囊性纤维化跨膜传导调节因子()基因实现了快速的基因型鉴定。NBS研究还揭示了基因变异的区域和人群差异,并驳斥了CF是“白人疾病”的教条。但一些地区尚未实施CF NBS,尤其是在疾病患病率尚不确定的亚洲。虽然一些低收入和中等收入国家的需求正在逐步得到满足,但目前最受关注的地区之一是印度次大陆,因为最近的数据表明其发病率高于先前的假设,并且临床观察表明,由于幼儿诊断延迟或未能诊断该疾病会导致悲惨后果。因此,我们得出结论,在印度次大陆进行研究与服务的机会非常迫切且可能具有很大影响力。因此,正如我们在此所主张的,印度是CF NBS的理想之地。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b3b/12015907/b4f460246c40/IJNS-11-00027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b3b/12015907/b4f460246c40/IJNS-11-00027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b3b/12015907/b4f460246c40/IJNS-11-00027-g001.jpg

相似文献

1
India: The Last and Best Frontier for Cystic Fibrosis Newborn Screening with Perspectives on Special Challenges.印度:囊性纤维化新生儿筛查的最后也是最佳前沿阵地及特殊挑战透视
Int J Neonatal Screen. 2025 Apr 17;11(2):27. doi: 10.3390/ijns11020027.
2
Why cystic fibrosis newborn screening programs have failed to meet original expectations… thus far.为什么囊性纤维化新生儿筛查计划迄今为止未能达到最初的期望……
Mol Genet Metab. 2023 Sep-Oct;140(1-2):107679. doi: 10.1016/j.ymgme.2023.107679. Epub 2023 Aug 6.
3
Variation in cystic fibrosis newborn screening algorithms in the United States.美国囊性纤维化新生儿筛查算法的差异。
Pediatr Pulmonol. 2023 Mar;58(3):927-933. doi: 10.1002/ppul.26279. Epub 2022 Dec 16.
4
Severe lung disease in children with cystic fibrosis missed in newborn screening.新生儿筛查漏诊的囊性纤维化患儿的严重肺部疾病
Pediatr Pulmonol. 2024 Jan;59(1):163-168. doi: 10.1002/ppul.26734. Epub 2023 Oct 27.
5
Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.丹麦囊性纤维化新生儿筛查:头 2 年的经验。
Pediatr Pulmonol. 2020 Feb;55(2):549-555. doi: 10.1002/ppul.24564. Epub 2019 Nov 4.
6
Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.新生儿筛查中疑似囊性纤维化患儿的免疫反应性胰蛋白酶原水平。
BMC Pediatr. 2019 Oct 22;19(1):369. doi: 10.1186/s12887-019-1756-4.
7
Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.囊性纤维化跨膜传导调节因子相关代谢综合征及囊性纤维化筛查呈阳性、诊断不确定
J Pediatr. 2017 Feb;181S:S45-S51.e1. doi: 10.1016/j.jpeds.2016.09.066.
8
Evaluation of specificity and sensitivity of IRT/IRT protocol in the cystic fibrosis newborn screening program: 6-year experience of three tertiary centers.IRT/IRT方案在囊性纤维化新生儿筛查项目中的特异性和敏感性评估:三个三级中心的6年经验
Eur J Pediatr. 2023 Mar;182(3):1067-1076. doi: 10.1007/s00431-022-04766-4. Epub 2022 Dec 24.
9
Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities.提高加利福尼亚新生儿筛查计划对所有种族和族裔的囊性纤维化检测率。
Pediatr Pulmonol. 2024 Nov;59(11):2901-2909. doi: 10.1002/ppul.27155. Epub 2024 Jun 28.
10
Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.土耳其一项新生儿筛查计划中的遗传诊断实验室现状和与囊性纤维化相关的遗传变异频率。
Genes (Basel). 2021 Jan 31;12(2):206. doi: 10.3390/genes12020206.

本文引用的文献

1
Implementing and validating newborn screening for inborn errors of metabolism in South India: a 2-year observational study at a tertiary care hospital.在印度南部实施并验证先天性代谢缺陷的新生儿筛查:一家三级护理医院的两年观察性研究。
BMJ Public Health. 2024 Nov 27;2(2):e001459. doi: 10.1136/bmjph-2024-001459. eCollection 2024 Dec.
2
Consolidated Newborn Bloodspot Screening Efforts in Developing Countries in the Asia Pacific-2024.2024年亚太地区发展中国家新生儿血斑筛查整合工作
Int J Neonatal Screen. 2024 Dec 30;11(1):2. doi: 10.3390/ijns11010002.
3
Linkages between consanguinity, pregnancy outcomes and offspring mortality in twenty-first century India.
21 世纪印度近亲婚姻、妊娠结局与子女死亡率的关联
Sci Rep. 2024 Sep 28;14(1):22522. doi: 10.1038/s41598-024-69151-7.
4
mutations and phenotypic correlations in people with cystic fibrosis: a retrospective study from a single centre in south India.囊性纤维化患者的突变与表型相关性:来自印度南部单一中心的回顾性研究
Lancet Reg Health Southeast Asia. 2024 Jun 11;27:100434. doi: 10.1016/j.lansea.2024.100434. eCollection 2024 Aug.
5
Improving newborn screening in India: Disease gaps and quality control.提高印度新生儿筛查水平:疾病缺口与质量控制。
Clin Chim Acta. 2024 Apr 15;557:117881. doi: 10.1016/j.cca.2024.117881. Epub 2024 Mar 21.
6
High carrier frequency of CYP21A2 gene mutations in Southern India - underscoring the need for genetic testing in Congenital Adrenal Hyperplasia.印度南部CYP21A2基因突变的高携带频率——强调先天性肾上腺皮质增生症基因检测的必要性。
Endocrine. 2024 Jul;85(1):363-369. doi: 10.1007/s12020-024-03747-x. Epub 2024 Mar 5.
7
Pseudo-Bartter syndrome as the initial presentation of cystic fibrosis in children: an important diagnosis not to be missed.儿童囊性纤维化以假性巴特综合征为首发表现:一个不容忽视的重要诊断。
BMJ Case Rep. 2024 Jan 31;17(1):e257348. doi: 10.1136/bcr-2023-257348.
8
Neonatal Screening for Congenital Adrenal Hyperplasia in Indian Newborns with Reflex Genetic Analysis of 21-Hydroxylase Deficiency.对印度新生儿进行先天性肾上腺皮质增生症的新生儿筛查,并对21-羟化酶缺乏症进行反射性基因分析。
Int J Neonatal Screen. 2023 Feb 21;9(1):9. doi: 10.3390/ijns9010009.
9
Missed Cystic Fibrosis Newborn Screening Cases due to Immunoreactive Trypsinogen Levels below Program Cutoffs: A National Survey of Risk Factors.因免疫反应性胰蛋白酶原水平低于项目临界值导致的囊性纤维化新生儿筛查漏诊病例:一项全国性危险因素调查
Int J Neonatal Screen. 2022 Oct 27;8(4):58. doi: 10.3390/ijns8040058.
10
Immunoreactive trypsinogen in healthy newborns and infants with cystic fibrosis.健康新生儿和囊性纤维化婴儿中的免疫反应性胰蛋白酶原。
Arch Dis Child Fetal Neonatal Ed. 2023 Mar;108(2):176-181. doi: 10.1136/archdischild-2021-323549. Epub 2022 Sep 8.